By Jonathan Stempel
(Reuters) -Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded the state's Medicaid program over alleged quality control lapses in a medicine to treat attention deficit hyperactivity disorder in children.
Texas Attorney General Ken Paxton said on Wednesday the settlement resolves a November 2023 lawsuit accusing the companies of manipulating testing for Quillivant XR between 2012 and 2018, to ensure it would comply with federal law and remain eligible for sale.
Paxton said properly done tests often showed the liquid medicine failed to dissolve in the body and was therefore ineffective. He said the defendants' actions violated the Texas Health Care Program Fraud Prevention Act.
"Under my watch, Big Pharma will not escape justice for lying about the effectiveness of its drugs," Paxton said in a statement.
Pfizer denied wrongdoing in agreeing to settle. In a statement, the New York-based drugmaker added that its review of Paxton's claims did not find any impact on the safety of the product for patients.
Tris did not immediately respond to a request for comment. Paxton's office did not immediately respond to a similar request.
The lawsuit stemmed from a whistleblower complaint by Tarik Ahmed, who was Tris' technology chief from 2013 to 2017.
Quillivant was developed by NextWave Pharmaceuticals, which Pfizer bought in 2012. Tris manufactured Quillivant for Pfizer until 2018, when it bought the medicine.
Paxton is running for the U.S. Senate in 2026 and is expected to face incumbent Senator John Cornyn in the Republican primary.
(Reporting by Jonathan Stempel in New York; Editing by Richard Chang)
LATEST POSTS
- 1
Down to earth Manual for A Modest Hyundai Ioniq Electric for Seniors - 2The Way to Fruitful Weight reduction: Individual Wellbeing Excursions
- 3Vaccine committee votes to scrap universal hepatitis B shots for newborns despite outcry from children’s health experts
- 4'Pluribus' release date: Everything you need to know about the new series from 'Better Call Saul's' co-creator
- 5Hamas delegation meets Egypt’s spy chief amid mutual ceasefire violation claims
- Meet ‘NASA Mike,’ who’s done 105,000 handstands around the world
- Meet the Stars of the Feline World: Well known Pet Feline Varieties
- The most effective method to Augment Benefits in Gold Speculation: Systems and Tips
- Artemis II astronauts will see parts of the moon no human has before. Here’s how
- Skeleton of famed musketeer possibly found in Dutch church
- Nick Reiner's defense attorney asks to be replaced, again delaying arraignment in connection with the stabbing deaths of his parents, Rob Reiner and Michele Singer Reiner
- Met Gala 2026 will celebrate fashion as an 'embodied art form': A guide to the theme, dress code, cochairs and hosting committee of the starry event
- Rediscovering Experience Through Excursions: Individual Travel Stories
- Winter storm headed for Midwest to Northeast. Here's how much snow to expect.
